Factors associated with completeness in documentation of diagnostic work-up and treatment in patients with breast cancer in Sudan
- PMID: 38414946
- PMCID: PMC10898882
- DOI: 10.3332/ecancer.2023.1632
Factors associated with completeness in documentation of diagnostic work-up and treatment in patients with breast cancer in Sudan
Abstract
Purpose: This study evaluates the relationship between geography and ethnicity on the completeness of documentation of diagnostic work-up and treatment modalities in Sudan for patients with breast cancer.
Methods: This retrospective study used data abstracted from patients with breast cancer receiving cancer care at Sudan's largest cancer centre (Radiation and Isotopes Center Khartoum) in 2017. Patient demographic and clinical characteristics were abstracted from paper medical records. Odds ratios and 95% confidence intervals were estimated to evaluate complete diagnostic work-up on ethnic group, origin and residence using binomial logistic regression models.
Results: Of 237 patients, the median age was 52 (interquartile range 43-61). Most often patients identified as Arab (68%), originated from Central, Northeastern and Khartoum regions (all 28%) and lived in the Khartoum region (52%). Overall, 49% had incomplete diagnostic work-up, with modest differences by ethnicity and geography. In adjusted analyses, non-statistical differences were found between the ethnic group, geographic origin and residence and having complete diagnostic work-up. For treatment modality, significant differences were observed between receptor status and receiving hormone therapy (p = 0.004). Only 28% of patients with HR+ breast cancer received hormonal therapy. For those with HR- or undocumented breast cancer subtype, 36% and 17% received hormone therapy, respectively.
Conclusion: Approximately half of Sudanese patients with breast cancer had incomplete diagnostic work-up, irrespective of ethnicity and geography. Moreover, a high proportion of patients received inappropriate treatment. This underlines a considerable systems-based quality gap in care delivery, demanding efforts to improve diagnostic work-up for all patients with breast cancer in Sudan.
Keywords: breast cancer; incomplete documentation; receptor status; sub-Saharan Africa.
© the authors; licensee ecancermedicalscience.
Conflict of interest statement
Dr Rocque received research funding from Genentech, Pfizer and Carevive and consulting fees for Genentech and Pfizer. All other authors declare they have no conflicts of interest.
Figures
Similar articles
-
Age at menarche of schoolgirls in Khartoum.Ann Hum Biol. 1983 Mar-Apr;10(2):185-8. doi: 10.1080/03014468300006321. Ann Hum Biol. 1983. PMID: 6838164
-
Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa.Histopathology. 2008 Mar;52(4):445-56. doi: 10.1111/j.1365-2559.2008.02966.x. Histopathology. 2008. PMID: 18315597
-
Sudan's national mental health programme and burden of mental illness.Int Psychiatry. 2009 Jan 1;6(1):16-18. eCollection 2009 Jan. Int Psychiatry. 2009. PMID: 31507974 Free PMC article.
-
Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.Cochrane Database Syst Rev. 2020 Mar 6;3(3):CD013538. doi: 10.1002/14651858.CD013538. Cochrane Database Syst Rev. 2020. PMID: 32141074 Free PMC article.
-
Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.Cochrane Database Syst Rev. 2021 May 26;5(5):CD011220. doi: 10.1002/14651858.CD011220.pub2. Cochrane Database Syst Rev. 2021. PMID: 34037241 Free PMC article.
References
-
- Mariani-Costantini R, Elhassan MMA, Aceto GM, et al. Breast Cancer-From Biology to Medicine. Pescara: Università degliStudi “G. d'Annunzio” Chieti; 2017. Epidemiology, pathology, management and open challenges of breast cancer in central Sudan: a prototypical limited resource African setting. - DOI
-
- Mushonga M, Ndlovu N, Nyakabau AM, et al. Biomarkers in breast cancer: quantifying discordance with best practice when hormone receptor status is an extravagance. S Afr J Oncol. 2020;4:1–8. doi: 10.4102/sajo.v4i0.134. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous